Saskia Winterfeld*
Pharmacogenomics, the study of how genes affect a person’s response to drugs, has emerged as a pivotal field in cancer treatment. By integrating genetic profiling with therapeutic strategies, healthcare providers can tailor treatments to individual patients, potentially improving efficacy and reducing adverse effects. This article reviews the current state of pharmacogenomics in cancer therapy, examining its role in personalized medicine, the challenges in implementation, and the future directions of this evolving field. By highlighting key studies and advancements, we underscore the transformative potential of pharmacogenomics in enhancing cancer treatment outcomes.
English 
Spanish 
Chinese 
Russian 
French 
Japanese 
Portuguese 
Hindi